Comparison of the clinical efficacy and safety of salmeterol/fluticasone propionate versus current care in the management of persistent asthma in Korea

Current Medical Research and Opinion

Volumn 24, Issue 12, 2008, Pages 3571-3582

  Jung, Ki Suck ^a   Uh, Soo Taek ^b   Lee, Yong Chul ^c   Shim, Jae Jeong ^d   Park, Soon Kew ^e   Williams, Angela E ^f   Chan, Robert ^f  

^a Hallym University   (South Korea)

^b Soonchunhyang University   (South Korea)

^c Chonbuk National University Medical School and Hospital   (South Korea)

^d Korea University   (South Korea)

^e Pusan National University   (South Korea)

^f GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Current care; Persistent asthma; Salmeterol fluticasone propionate combination

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; FLUTICASONE PROPIONATE PLUS SALMETEROL; LEUKOTRIENE RECEPTOR BLOCKING AGENT; ANDROSTANE DERIVATIVE; BRONCHODILATING AGENT; DRUG DERIVATIVE; FLUTICASONE; SALBUTAMOL; SALMETEROL;

ADULT; AGED; ALLERGIC RHINITIS; ARTHRALGIA; ARTICLE; ASTHMA; BRONCHITIS; CLINICAL TRIAL; CONJUNCTIVITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG EFFICACY; DRUG SAFETY; DYSPEPSIA; FEMALE; FORCED EXPIRATORY VOLUME; GASTRITIS; HEADACHE; HUMAN; INCIDENCE; KOREA; MAJOR CLINICAL STUDY; MALE; MYALGIA; OUTCOME ASSESSMENT; PATIENT CARE; PEAK EXPIRATORY FLOW; PHARYNGITIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RHINITIS; RHINOPHARYNGITIS; SINUSITIS; THRUSH; TONSILLITIS; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION; ADOLESCENT; ASIAN; COMPARATIVE STUDY; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY;

ADOLESCENT; ADULT; AGED; ALBUTEROL; ANDROSTADIENES; ASIAN CONTINENTAL ANCESTRY GROUP; ASTHMA; BRONCHODILATOR AGENTS; FEMALE; HUMANS; KOREA; MALE; MIDDLE AGED;

EID: 62349105475     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007990802588737     Document Type: Article

References (27)

1. Beasley R, Crane J, Lai CK, et al. Prevalence and aetiology of asthma. J Allergy Clin Immun 2000;105:S466-S472
2. Braman SS. The global burden of asthma. Chest 2006;30:4S-12S
3. Innes Asher M, Montefort S, Björkstén B, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhino-conjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006;368:733-743
4. Global initiative for asthma (GINA). Global strategy for asthma management and prevention. National Institutes of Health publication No. 02-3659, revised 2006
5. Barnes PJ. Drugs for airway disease. Medicine 2008;36:181-190
6. Greening AP, Ind PW, Northfield M, et al. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 1994;344:219-224
7. Woolcock A, Lundback B, Ringdal N, et al. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med 1996;153:1481-1488
8. Rabe KF, Adachi M, Lai C, et al. Worldwide severity and control of asthma in children and adults: The global Asthma and Insights Reality surveys. J Allergy Clin Immun 2004;114:40-47
9. Rabe K, Vermeire P, Soriano J, et al. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Resp J 2000;16:802-880
10. Lai C, de Guia T, Kim Y-Y, et al. Asthma control in the Asia- Pacific region: The Asthma Insights and reality in Asia-Pacific Study. J Allergy Clin Immun 2003;111:263-268
11. Neffen H, Fritscher C, Schacht FC, et al. Asthma control in Latin America: the Asthma Insights and Reality in Latin America (AIRLA) survey. Rev Panam Salud Publica 2005;17:191-197
12. Cho S-H, Park H-W, Rosenberg DM. The current status of asthma in Korea. J Korean Med Sci 2006;21:181-187
13. Standardization of Lung Function Tests as contained in the report of the working party of the European Community for Coal and Steel. Bull Eur Physiopath Resp 1983;19 [Suppl. 5]:1-95
14. Juniper EF, Guyatt GH, Cox FM, et al. Development and validation of the Mini Asthma Quality of Life Questionnaire. Eur Respir J 1999;4:32-38
15. Nathan RA, Sorkness CA, Kosinski M, et al. Development of the Asthma Control Test: a survey for assessing asthma control. J Allergy Clin Immun 2004;113:59-65
16. Schatz M, Sorkness CA, Li JT. Asthma control test: reliability, validity and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immun 2006;117:549-556
17. Juniper EF, Guyatt GH, Willan A, et al. Determining a minimal important change in a disease-specific quality of life questionnaire. J Clin Epidemiol 1994;47:81-87
18. Senn SJ. Base logic: Tests of baseline balance in randomised clinical trails. Clin Res Regul Aff 1995;12(3):171-182
19. Bateman E, Boushey H, Bousquet J, et al. Can guideline-asthma control be achieved? The Gaining Optimal Asthma ControL Study. Am J Respir Crit Care Med 2004;170:836-844
20. Spencer S, Mayer B, Bendall KL, et al. Validation of a guideline-based composite outcome assessment tool for asthma control. Respir Res 2007;8:26
21. Dahl R, Chuchalin A, Gor D, et al. EXCEL: a randomised trial comparing salmeterol/fluticasone propionate and formoterol/budesonide combinations in adults with persistent asthma. Respir Med 2006;100:1152-1162
22. Calhoun WJ, Nelson HS, Nathan RA, et al. Comparison of fluticasone propionate-salmeterol combination therapy and montelukast in patients who are symptomatic on shortacting beta2-agonists alone. Am J Resp Crit Care Med 2001;164:759-763
23. Nelson HS, Busse WW, Kerwin E, et al. Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast. J Allergy Clin Immun 2000;106:1088-1095
24. Fish JE, Israel E, Murray JJ, et al. Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy. Chest 2001;120:423-430
25. Ringdal N, Eliraz A, Pruzinec R, et al. The salmeterol/fluticasone combination is more effective than fluticasone plus oral montelukast in asthma. Respir Med 2003;97:234-241
26. Adachi M, Aizawa H, Ishihara K, et al. COMPARISON of fluticasone propionate plus theophylline with the salmeterol/fluticasone propionate combination in Japanese asthmatics. 15th Annual Congress of the European Respiratory Society 2005, Abs 397
27. Sheth K, Borker R, Emmett A, et al. Cost-effectiveness comparison of salmeterol/fluticasone propionate versus montelukast in the treatment of adults with persistent asthma. Pharmacoeconomics 2002;20:909-918